Chee Khoon Lee, Apriliana E. R. Kartikasari, Nirashaa T. Bound, Katherine E. Francis, Kristy Shield-Artin, Justin Bedo, Ksenija Nesic, Katrina Diamante, Rachel L. O’Connell, Mutsa Madondo, Momodou Cox, Claire Davies, Cyril Deceneux, Georgia Goodchild, Andrew Jarratt, Emily Cassar, Hina Amer, U. G. Imalki U. Kariyawasam, Yeh Chen Lee, Janine Lombard, Sally Baron-Hay, Yoland Antill, Catherine Shannon, Sudarshan Selva-Nayagam, Philip Beale, Danka Zebic, Sandy Simon, Anneliese Linaker, Michael A. Quinn, Anthony T. Papenfuss, Matthew J. Wakefield, Cassandra J. Vandenberg, Michael Friedlander, Clare L. Scott, Magdalena Plebanski. "Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial." Nature Communications, 2025. doi:10.1038/s41467-025-64130-6